Sanofi Pasteur Inc. drugs

2 results

  • beyfortus - nirsevimab injection

    (Nirsevimab)
    Sanofi Pasteur Inc.
    Beyfortus prevents RSV lower respiratory tract disease in neonates and infants during their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
    Medication Details
    Drug Interactions

  • ipol

    (Poliovirus Type 1 Antigen (Formaldehyde Inactivated), Poliovirus Type 2 Antigen (Formaldehyde Inactivated), And Poliovirus Type 3 Antigen (Formaldehyde Inactivated))
    Sanofi Pasteur Inc.
    Medication Details